Literature DB >> 17654506

Pyruvate kinase deficiency associated with severe liver dysfunction in the newborn.

Martine F Raphaël1, Richard Van Wijk, Joachim J Schweizer, Netteke A Y Schouten-van Meeteren, Angelika Kindermann, Wouter W van Solinge, Frans J Smiers.   

Abstract

Significant hyperbilirubinaemia, anemia, and splenomegaly are common features in patients with severe haemolysis due to pyruvate kinase (PK) deficiency. Until now, severe neonatal PK deficiency has not been associated with fatal liver disease at this age. We present two neonatal cases of severe PK deficiency complicated with progressive fatal liver disease. The patients presented with severe haemolysis, progressive cholestasis, and hepatosplenomegaly, and both patients ultimately developed liver failure at a very young age. Despite extensive investigations, no specific explanation for liver disease and failure was found. We suggest that the PK deficiency itself directly led to liver dysfunction. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17654506     DOI: 10.1002/ajh.20942

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  8 in total

1.  Rapid Identification of Biallelic SPTB Mutation in a Neonate with Severe Congenital Hemolytic Anemia and Liver Failure.

Authors:  Christopher M Richmond; Sally Campbell; Hee W Foo; Sebastian Lunke; Zornitza Stark; Amanda Moody; Elizabeth Bannister; Anthea Greenway; Natasha Brown
Journal:  Mol Syndromol       Date:  2020-02-01

2.  Cooperating G6PD mutations associated with severe neonatal hyperbilirubinemia and cholestasis.

Authors:  Benjamin Mizukawa; Alex George; Suvarnamala Pushkaran; Lana Weckbach; KarenAnn Kalinyak; James E Heubi; Theodosia A Kalfa
Journal:  Pediatr Blood Cancer       Date:  2010-10-14       Impact factor: 3.167

Review 3.  Management of severe hyperbilirubinemia in the cholestatic neonate: a review and an approach.

Authors:  Jon F Watchko; M Jeffrey Maisels
Journal:  J Perinatol       Date:  2022-02-10       Impact factor: 3.225

4.  Addressing the diagnostic gaps in pyruvate kinase deficiency: Consensus recommendations on the diagnosis of pyruvate kinase deficiency.

Authors:  Paola Bianchi; Elisa Fermo; Bertil Glader; Hitoshi Kanno; Archana Agarwal; Wilma Barcellini; Stefan Eber; James D Hoyer; David J Kuter; Tabita Magalhães Maia; Maria Del Mar Mañu-Pereira; Theodosia A Kalfa; Serge Pissard; José-Carlos Segovia; Eduard van Beers; Patrick G Gallagher; David C Rees; Richard van Wijk
Journal:  Am J Hematol       Date:  2018-11-28       Impact factor: 10.047

5.  Genotype-phenotype correlation and molecular heterogeneity in pyruvate kinase deficiency.

Authors:  Paola Bianchi; Elisa Fermo; Kimberly Lezon-Geyda; Eduard J van Beers; Holmes D Morton; Wilma Barcellini; Bertil Glader; Satheesh Chonat; Yaddanapudi Ravindranath; Peter E Newburger; Nina Kollmar; Jenny M Despotovic; Madeleine Verhovsek; Mukta Sharma; Janet L Kwiatkowski; Kevin H M Kuo; Marcin W Wlodarski; Hassan M Yaish; Susanne Holzhauer; Heng Wang; Joachim Kunz; Kathryn Addonizio; Hasan Al-Sayegh; Wendy B London; Oliver Andres; Richard van Wijk; Patrick G Gallagher; Rachael F F Grace
Journal:  Am J Hematol       Date:  2020-03-06       Impact factor: 10.047

6.  Novel Compound Heterozygous PKLR Mutation Induced Pyruvate Kinase Deficiency With Persistent Pulmonary Hypertension in a Neonate: A Case Report.

Authors:  Sha Lin; Xintian Hua; Jinrong Li; Yifei Li
Journal:  Front Cardiovasc Med       Date:  2022-04-26

Review 7.  Erythrocyte pyruvate kinase deficiency: 2015 status report.

Authors:  Rachael F Grace; Alberto Zanella; Ellis J Neufeld; D Holmes Morton; Stefan Eber; Hassan Yaish; Bertil Glader
Journal:  Am J Hematol       Date:  2015-08-14       Impact factor: 10.047

Review 8.  Regulation of pyruvate metabolism and human disease.

Authors:  Lawrence R Gray; Sean C Tompkins; Eric B Taylor
Journal:  Cell Mol Life Sci       Date:  2013-12-21       Impact factor: 9.261

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.